...
首页> 外文期刊>Journal of Medicinal Chemistry >Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles
【24h】

Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles

机译:自由配体1D NMR构象签名,以增强基于结构的MCL-1抑制剂的药物设计(AZD5991)和其他合成宏γ

获取原文
获取原文并翻译 | 示例

摘要

The three-dimensional conformations adopted by a free ligand in solution impact bioactivity and physicochemical properties. Solution 1D NMR spectra inherently contain information on ligand conformational flexibility and three-dimensional shape, as well as the propensity of the free ligand to fully preorganize into the bioactive conformation. Herein we discuss some key learnings, distilled from our experience developing potent and selective synthetic macrocyclic inhibitors, including Mcl-1 clinical candidate AZD5991. Case studies have been selected from recent oncology research projects, demonstrating how 1D NMR conformational signatures can complement X-ray protein ligand structural information to guide medicinal chemistry optimization. Learning to extract free ligand conformational information from routinely available 1D NMR signatures has proven to be fast enough to guide medicinal chemistry decisions within design cycles for compound optimization.
机译:自由配体在溶液中采用的三维构象冲击生物活性和物理化学性质。 溶液1D NMR光谱固有地含有关于配体构象灵活性和三维形状的信息,以及自由配体的倾向完全整植于生物活性构象。 在此,我们讨论了一些关键的学习,从我们的经验中蒸馏出效率和选择性合成宏环抑制剂,包括MCL-1临床候选AZD5991。 案例研究已选自最近的肿瘤学研究项目,展示了1D NMR构象签名可以补充X射线蛋白配体结构信息以引导药物化学优化。 学习从常规可用的1D NMR签名中提取自由配体的构象信息已经证明已经足够快,以指导设计周期内的药物化学决策进行复合优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号